From quantum to clinic: AI reshapes clinical trials
The burden of conducting clinical trials is a significant hurdle in drug discovery. Here, Dr Mark Lambrecht reveals the technological developments that are driving shifts in this space.
List view / Grid view
The burden of conducting clinical trials is a significant hurdle in drug discovery. Here, Dr Mark Lambrecht reveals the technological developments that are driving shifts in this space.
The CRDMO will support the biotech company’s work on next-generation immunotherapies for oncology and autoimmune diseases.
Study highlights potential of novel system for continuous, automated production of albuterol sulfate, an API on the US FDA’s drug shortage list.
The regulators’ 10 principles aim to support pharma companies with evidence generation and monitoring for new medicines.
Digital twin model offers potential for advanced control during continuous pharmaceutical manufacturing processes.
The quality control (QC) standards publication sets animal-free bacterial endotoxins testing (BET) as the new norm in Europe.
The impurities research illustrates an approach that could offer a simpler and more flexible downstream purification process.
UK biotech commits to scale up of 228Th extraction and a long-term supply agreement to facilitate production of thousands of doses of 212Pb for cancer therapies annually.
Moderna’s $500 million deal with Nanexa will focus on improving long-acting injectable drug delivery, potentially improving mRNA medicines.
CDMOs weigh up how to meet manufacturing demands across oral solid doses, monoclonal antibodies, ADCs and beyond.
MBV AG addresses challenges in air monitoring and aseptic handling with MAS-100 Sirius®: a next‑generation active microbial air sampler created in close collaboration with pharmaceutical manufacturers and cleanroom experts.
Nippon Muki demonstrates the performance advantages of its innovative HEPA filter for the sterilisation of injectable containers in pharmaceutical manufacturing.
EPR Issue 4 includes articles on manufacturing, AI/ML, vaccine development, biologics and more.
The innovative approach for detecting nitrosamine impurities in APIs addresses limitations of traditional mass-based techniques, research says.
The proposed mechanical antibacterial approach offers a new way to use metal-organic frameworks, a Nobel Prize-winning material.